Research programme: HIF-1 alpha inhibitors - Xenova

Drug Profile

Research programme: HIF-1 alpha inhibitors - Xenova

Alternative Names: HIF-1 alpha inhibitors research programme - Xenova

Latest Information Update: 28 Jul 2004

Price : $50

At a glance

  • Originator Xenova Group
  • Class
  • Mechanism of Action Hypoxia-inducible factor-1 alpha inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 28 Jul 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
  • 18 Dec 2002 Preclinical trials in Cancer in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top